Is NCT03158025 results overdue?

Yes — results are overdue. Primary completion was 2018-07-04; the FDAAA-801 reporting deadline (2019-07-04) passed 2590 days ago and no results are posted on ClinicalTrials.gov.

A Study to Determine the Abuse Potential of Single Oral Doses of Lemborexant Compared to Zolpidem, Suvorexant and Placebo in Healthy, Non-Dependent, Recreational Sedative Users

NCT ID	NCT03158025 ↗
Sponsor	Eisai Inc. (INDUSTRY)
Phase	PHASE1
Status	COMPLETED
Primary completion	2018-07-04 (ACTUAL)
Reporting deadline	2019-07-04 (completion + 365d)
Days overdue	2590
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-06-21 · SHA-256 `3674c63b004c9489…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03158025. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.